UB Paderborn / Katalog / Suche / in CDI

Global absence and targeting of protective immune states in severe COVID-19

Nature (London), 2021-03, Vol.591 (7848), p.124

2021

Volltextzugriff (PDF)

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

Science translational medicine, 2021-09, Vol.13 (612), p.eabh2624

2021

Volltextzugriff (PDF)

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

The Lancet. Healthy longevity, 2021-03, Vol.2 (3), p.e163-e170

2021

Volltextzugriff (PDF)

The impact of new onset anaemia on morbidity and mortality in chronic heart failure : results from COMET

European heart journal, 2006-06, Vol.27 (12), p.1440-1446

2006

Volltextzugriff (PDF)

An epidemiological introduction to human metabolomic investigations

Trends in endocrinology and metabolism, 2023-09, Vol.34 (9), p.505-525

2023

Volltextzugriff (PDF)

Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients

Immunity (Cambridge, Mass.), 2022-07, Vol.55 (7), p.1284-1298.e3

2022

Volltextzugriff (PDF)

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients

European heart journal, 2021-09, Vol.42 (35), p.3541-3554

2021

Volltextzugriff (PDF)

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

European heart journal, 2005-11, Vol.26 (21), p.2259-2268

2005

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Heart (British Cardiac Society), 2007-08, Vol.93 (8), p.968-973

2007

Volltextzugriff (PDF)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

The Lancet (British edition), 2003-07, Vol.362 (9377), p.7-13

2003

Volltextzugriff (PDF)

Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

European journal of heart failure, 2007-08, Vol.9 (8), p.795-801

2007

Volltextzugriff (PDF)

Unexpected versus all-cause mortality as the endpoint for investigating the effects of a Rapid Response System in hospitalized patients

Critical care (London, England), 2016-06, Vol.20 (1), p.168-168, Article 168

2016

Volltextzugriff (PDF)

Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

European journal of heart failure, 2007-09, Vol.9 (9), p.901-909

2007

Volltextzugriff (PDF)

A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET)

Journal of the American College of Cardiology, 2006-04, Vol.47 (8), p.1603-1611

2006

Volltextzugriff (PDF)

COvid MEdicaTion (COMET) study: protocol for a cohort study

European journal of hospital pharmacy. Science and practice, 2020-07, Vol.27 (4), p.191-193

2020

Volltextzugriff (PDF)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Nature communications, 2019-10, Vol.10 (1), p.4955-14, Article 4955

2019

Volltextzugriff (PDF)

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Science immunology, 2023-12, Vol.8 (90), p.eabp8966

2023

Volltextzugriff (PDF)

Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup

Mutation research, 2007-02, Vol.627 (1), p.31-35

2007

Volltextzugriff (PDF)

COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective

American journal of respiratory and critical care medicine, 2022-10, Vol.206 (8), p.961-972

2022

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

PLoS genetics, 2011-07, Vol.7 (7), p.e1002178-e1002178

2011

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

The American heart journal, 2005-02, Vol.149 (2), p.370-376

2005

Volltextzugriff (PDF)

Azimilide vs. placebo and sotalol for persistent atrial fibrillation : the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial

European heart journal, 2006-09, Vol.27 (18), p.2224-2231

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Global absence and targeting of protective immune states in severe COVID-19

Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study

The impact of new onset anaemia on morbidity and mortality in chronic heart failure : results from COMET

An epidemiological introduction to human metabolomic investigations

Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

Unexpected versus all-cause mortality as the endpoint for investigating the effects of a Rapid Response System in hospitalized patients

Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET)

COvid MEdicaTion (COMET) study: protocol for a cohort study

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup

COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

Azimilide vs. placebo and sotalol for persistent atrial fibrillation : the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial

Aktive Filter

Suchergebnisse filtern